Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Cardiovascular pharmacology core reviews: aspirin.

Gaglia MA Jr, Clavijo L.

J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):505-13. doi: 10.1177/1074248413503043. Epub 2013 Sep 19. Review.

PMID:
24057863
2.

[Primary prevention with aspirin].

Divisón JA, Galgo A, Polo J, Durá R.

Semergen. 2012 Sep;38(6):366-76. doi: 10.1016/j.semerg.2012.01.006. Epub 2012 May 10. Spanish.

PMID:
22935833
3.

An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.

Kolber MR, Korownyk C.

Expert Opin Pharmacother. 2014 Feb;15(2):153-7. doi: 10.1517/14656566.2014.853039. Epub 2013 Nov 11.

PMID:
24206142
4.

Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.

Schnell O, Erbach M, Hummel M.

Diab Vasc Dis Res. 2012 Oct;9(4):245-55. Epub 2012 Apr 16. Review.

PMID:
22508698
5.

Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes.

Berger JS.

Am J Cardiol. 2013 Sep 1;112(5):737-45. doi: 10.1016/j.amjcard.2013.04.055. Epub 2013 Jun 7. Review.

PMID:
23751937
6.

Drug insight: aspirin resistance--fact or fashion?

Patrono C, Rocca B.

Nat Clin Pract Cardiovasc Med. 2007 Jan;4(1):42-50. Review.

PMID:
17180149
7.

The role of aspirin in the prevention of cardiovascular disease.

Ittaman SV, VanWormer JJ, Rezkalla SH.

Clin Med Res. 2014 Dec;12(3-4):147-54. doi: 10.3121/cmr.2013.1197. Epub 2014 Feb 26. Review.

8.

[Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].

Klomp CM, ten Cate H, Stehouwer CD, Schaper NC.

Ned Tijdschr Geneeskd. 2009;153:A109. Review. Dutch.

PMID:
19785798
9.

Antiplatelet therapy: controversial aspects.

Coccheri S.

Thromb Res. 2012 Mar;129(3):225-9. doi: 10.1016/j.thromres.2011.10.036. Epub 2011 Nov 25. Review.

PMID:
22119155
10.

Aspirin for the prevention of cardiovascular events in the elderly.

Mahé I, Leizorovicz A, Caulin C, Bergmann JF.

Drugs Aging. 2003;20(13):999-1010. Review.

PMID:
14561103
11.

Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.

Colwell JA.

Am J Cardiovasc Drugs. 2004;4(2):87-106. Review.

PMID:
15049721
12.

Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review.

Bem D, Dretzke J, Stevens S, Lordkipanidzé M, Hodgkinson J, Bayliss S, Moore D, Fitzmaurice D.

Syst Rev. 2015 Jun 19;4:88. doi: 10.1186/s13643-015-0078-3. Review.

13.

Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact.

Papathanasiou A, Goudevenos J, Tselepis AD.

Curr Pharm Des. 2009;15(10):1085-94. Review.

PMID:
19355950
14.

Aspirin in primary and secondary prevention in elderly adults revisited.

Wilson R, Gazzala J, House J.

South Med J. 2012 Feb;105(2):82-6. doi: 10.1097/SMJ.0b013e3182426eef. Review.

PMID:
22267096
15.

Aspirin for primary prevention of cardiovascular disease?

[No authors listed]

Drug Ther Bull. 2009 Nov;47(11):122-5. doi: 10.1136/dtb.2009.10.0045. Erratum in: Drug Ther Bull. 2010 Feb;48(2):24.

PMID:
19887685
16.

Aspirin for primary prevention of cardiovascular disease events.

Nemerovski CW, Salinitri FD, Morbitzer KA, Moser LR.

Pharmacotherapy. 2012 Nov;32(11):1020-35. doi: 10.1002/phar.1127. Epub 2012 Sep 27. Review.

PMID:
23019080
17.

Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.

U.S. Preventive Services Task Force.

Am J Nurs. 2002 Mar;102(3):67, 69-70. Review. No abstract available.

PMID:
11976531
18.

Statins and aspirin: do they really work in women?

Desai H, Hollingsworth PW, Chugh AR.

Am J Cardiovasc Drugs. 2015 Jun;15(3):151-62. doi: 10.1007/s40256-015-0111-x. Review.

PMID:
25812803
19.

The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders.

Cohen AT, Imfeld S, Markham J, Granziera S.

Thromb Res. 2015 Feb;135(2):217-25. doi: 10.1016/j.thromres.2014.11.036. Epub 2014 Dec 13. Review.

PMID:
25541030
20.

Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.

Bliden KP, Patrick J, Pennell AT, Tantry US, Gurbel PA.

Future Cardiol. 2016 Jan;12(1):45-58. doi: 10.2217/fca.15.60. Epub 2015 Sep 10. Review.

Items per page

Supplemental Content

Write to the Help Desk